Use of Magnetocardiography in Evaluation of Patients Going for Cardiac Catheterization

Last updated: May 21, 2020
Sponsor: Genetesis Inc.
Overall Status: Terminated

Phase

N/A

Condition

Thrombosis

Heart Disease

Angina

Treatment

N/A

Clinical Study ID

NCT04044391
1345773
  • Ages > 18
  • All Genders

Study Summary

This is a multicenter, prospective trial to measure the test performance characteristics of the Magnetocardiography (MCG) CardioFlux cardiac diagnostic system in detecting clinically significant coronary artery obstruction in patients with symptoms of suspected acute coronary syndrome or who present with a failed stress test with the intention of treat with cardiac catheterization.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age ≥ 18 years of age at the time of enrollment.

  • Patient presenting acutely with signs and symptoms suggestive of Acute CoronarySyndrome (ACS) and in the opinion of the treating physician and based on best clinicalassessment that a cardiac catheterization will be performed; or, had a positive stresstest and is scheduled for cardiac catheterization.

  • Patient's ability to lay supine for five minutes.

Exclusion

Exclusion Criteria:

  • Age < 18 years of age

  • Patients unable to fit into device

  • Unable to transfer to device gantry

  • Positive response on magnetocardiography (MCG) prescreening form

  • Patients with claustrophobia or unable to lie supine for five minutes

  • Pregnant women

  • Poor candidate for follow-up (e.g. no access to phone)

  • Repeat participants

  • Prisoners

  • Acute STEMI or hemodynamically unstable patients (Mean Arterial Pressure ≤ 65,Respiratory Rate ≥24, Heart Rate ≥105 bpm, Temperature>38.1 or <34 degrees Celsius, O2Saturation<90% despite oxygen therapy).

  • Do not resuscitate order (DNR)

  • Unable to have a cardiac catheterization secondary to dye, allergy, creatinineclearance, can't obtain access, etc.

Study Design

Total Participants: 101
Study Start date:
May 15, 2019
Estimated Completion Date:
May 04, 2020

Study Description

This is a multicenter, prospective clinical trial studying the utility and accuracy of magnetocardiography (MCG) in identifying critical coronary artery obstruction responsible for myocardial ischemia. The study will enroll up to 1500 patients at high risk for coronary artery disease (CAD) who have been referred for cardiac catheterization. These patients will be recruited from an inpatient service post admission for chest pain or anginal equivalent or from a cohort of symptomatic patients who have failed outpatient stress testing. If they meet other stated inclusion criteria, they will have a 2 minute MCG scan prior to their cardiac catheterization. For comparative purposes, the first 300 patients will have an electrocardiogram (ECG) performed within 60 minutes of this initial scan.

After an enrolled study subject has had their catheterization procedure, the results of the catheterization will be reviewed by one of the study's primary investigators. If the subject has had a percutaneous coronary intervention (PCI), a second MCG scan will be performed prior to their discharge. The MCG scans will be interpreted by 3 physicians trained to read these images and blinded to all clinical information regarding study subjects.

The initial MCG scan will be evaluated for its sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and overall accuracy in detecting myocardial ischemia and critical coronary stenosis based on angiographic imaging, fractional flow reserve (FFR), or instant wave-free ratio (iFR) measurements, as applicable. The same statistical analysis will be performed for the ECGs performed on each of the applicable study subjects. When performed, the second MCG will be evaluated for any abnormalities after revascularization. These results will be used to determine the value of post-PCI MCG to predict 30 day and 180 day major adverse cardiac events (MACE)—specifically myocardial infarction or stroke, need for revascularization, or cardiac related death.

Connect with a study center

  • Ascension St. John Medical Center

    Detroit, Michigan 48236
    United States

    Site Not Available

  • Beaumont Hospital

    Royal Oak, Michigan 48073
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.